NCT04495712
Antiarrhythmic Effects of Spironolactone in Patients With ICDs
See it on ClinicalTrials.gov ↗90 people
95.6%
86 womenmiddle line = equal numbers4 men
- Phase
- PHASE4
- Paid for by
- VA Office of Research and Development
- Finished
- 2008-05-28
- Health conditions
- Ventricular Arrhythmias
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 66.5 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“primary hepatic failure,”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“unstable angina,”
Study titles and rules are shown in their original English.